BIAFW (NASDAQ) is a cross-listing of BIAF (NASDAQ). Showing primary listing data.
BIAF
bioAffinity Technologies, Inc.
1W: +28.8%
1M: +131.4%
3M: +111.6%
YTD: +123.8%
1Y: -68.2%
3Y: -94.5%
$2.73
-0.24 (-8.08%)
After Hours: $2.84 (+0.11, +4.21%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$12.3M
52W Range0.693-46.53
Volume14,438,447
Avg Volume6,921,988
Beta2.44
Dividend—
Analyst Ratings
Company Info
CEOMaria Zannes
Employees57
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2022-09-01
Websitebioaffinitytech.com
22211 West Interstate 10
San Antonio, TX 78257
US
San Antonio, TX 78257
US
210 698 5334
About bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.
Latest News
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Rios Roberto | 0 | — | 2025-08-12 | |
| Oppenheimer John J. | 0 | — | 2025-08-12 | |
| Reveles Xavier Trini | A-Award | 21,604 | — | 2025-01-10 |
| GIRGENTI STEVEN | A-Award | 14,814 | — | 2025-01-10 |
| Zannes Maria | A-Award | 37,037 | — | 2025-01-10 |